NCT00058994已完成3 期
An Evaluation of Safety and Efficacy of Anecortave Acetate Versus Placebo in Patients With Subfoveal Choroidal Neovascularization Due to Exudative Age-related Macular Degeneration
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 试验地点
- 1
研究概览
简要总结
The purpose of this study is to demonstrate that anecortave acetate is superior to placebo in maintenance of visual acuity at the 12- and 24-month visits.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 50 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients at least 50 years of age, of any race, and either sex with a clinical diagnosis of exudative AMD and a primary or recurrent subfoveal CNV lesion in the study eye.
排除标准
- 未提供
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
Anecortave Acetate in Subfoveal Choroidal Neovascularization (CNV) Due to Wet Age-Related Macular Degeneration (AMD)Maculopathy, Age-RelatedAge-Related MaculopathiesAge-Related MaculopathyMaculopathies, Age-RelatedMacular DegenerationNCT00051129Alcon Research291
已完成
2 期
Anecortave Acetate for Treatment of Steroid Induced Intraocular Pressure (IOP) ElevationEye DiseasesNCT00315640Alcon Research70
已完成
3 期
Phase 3 Study to Evaluate Anecortave Acetate vs. Visudyne for the Treatment of the Wet Form of AMDMacular DegenerationNCT00041483Alcon Research530
终止
3 期
Anecortave Acetate Risk Reduction Trial (AART)AMDNCT00332657Alcon Research36
尚未招募
2 期
Study of the Safety and Efficacy of Anercortave Acetate for Treatment of Steroid Induced IOP Elevatioincreased pressure inside the eye10015917ocular hypertensionNL-OMON30214ALCON/LABORATORIES6